Pub. Date : 1984 Aug
PMID : 6483118
10 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Effect of fentanyl and naloxone on the P300 auditory potential. | Fentanyl | E1A binding protein p300 | Homo sapiens |
2 | Effect of fentanyl and naloxone on the P300 auditory potential. | Naloxone | E1A binding protein p300 | Homo sapiens |
3 | The effect of fentanyl (opioid agonist) and naloxone (morphine antagonist) on the amplitude, area and latency of the P300 auditory potential was studied in patients undergoing minor surgical procedures. | Fentanyl | E1A binding protein p300 | Homo sapiens |
4 | The effect of fentanyl (opioid agonist) and naloxone (morphine antagonist) on the amplitude, area and latency of the P300 auditory potential was studied in patients undergoing minor surgical procedures. | Naloxone | E1A binding protein p300 | Homo sapiens |
5 | The effect of fentanyl (opioid agonist) and naloxone (morphine antagonist) on the amplitude, area and latency of the P300 auditory potential was studied in patients undergoing minor surgical procedures. | Morphine | E1A binding protein p300 | Homo sapiens |
6 | Concomitantly, fentanyl increased the number of omitted counts of the target tones of the "odd ball" P300 test and the spatial threshold of the two point discrimination test in patients with small and large P300 potentials. | Fentanyl | E1A binding protein p300 | Homo sapiens |
7 | Concomitantly, fentanyl increased the number of omitted counts of the target tones of the "odd ball" P300 test and the spatial threshold of the two point discrimination test in patients with small and large P300 potentials. | Fentanyl | E1A binding protein p300 | Homo sapiens |
8 | Naloxone significantly increased the amplitude and area and decreased the latency of the small P300 potential and decreased the amplitude and area with no changes in latency of the large P300 potentials. | Naloxone | E1A binding protein p300 | Homo sapiens |
9 | Concomitantly, naloxone decreased the number of omitted counts of the patients with small but not large P300 potentials and decreased the spatial threshold in patients with both small and large P300 potentials. | Naloxone | E1A binding protein p300 | Homo sapiens |
10 | Concomitantly, naloxone decreased the number of omitted counts of the patients with small but not large P300 potentials and decreased the spatial threshold in patients with both small and large P300 potentials. | Naloxone | E1A binding protein p300 | Homo sapiens |